Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
469 studies found for:    Open Studies | "Stomach Diseases"
Show Display Options
Rank Status Study
21 Recruiting Vagal Nerve Stimulation for Gastroparesis
Condition: Gastroparesis
Intervention: Device: Vagal Nerve Stimulation
22 Not yet recruiting Naloxegol for Opioid-Related Gastroparesis
Conditions: Gastroparesis;   Opioid Use
Interventions: Drug: Naloxegol 25 MG Oral Tablet [Movantik];   Drug: Placebo Oral Tablet
23 Recruiting Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis
Condition: Gastroparesis
Interventions: Drug: VLY-686 (Tradipitant);   Other: Placebo
24 Not yet recruiting Per-oral Endoscopy Pyloromyotomy (G-POEM) in the Treatment of Refractory Diabetic Gastroparesis : Prospective Evaluation of Efficacy
Condition: Gastroparesis
Interventions: Procedure: Per-oral endoscopy pyloromyotomy;   Procedure: Intrapyloric injection of Botulinum toxin
25 Not yet recruiting Monosodium Glutamate on Gastric Emptying
Condition: Delayed Gastric Emptying
Intervention: Dietary Supplement: Monosodium glutamate
26 Recruiting G-POEM for Treatment of Refractory Gastroparesis
Conditions: Diabetic Gastroparesis;   Idiopathic Gastroparesis;   Gastroparesis Postoperative
Intervention: Procedure: Gastric POEM
27 Recruiting Impact of Additional DJ (Duodenojejunostomy)-Pexy on Reduction in Delayed Gastric Emptying Following Pylorus-preserving Pancreaticoduodenectomy: A Prospective, Randomized Controlled Trial
Condition: Delayed Gastric Emptying
Interventions: Procedure: PPPD (pylorus-preserving pancreaticoduodenectomy);   Procedure: PPPD (pylorus-preserving pancreaticoduodenectomy) with DJ-pexy
28 Recruiting Prucalopride Versus Placebo in Gastroparesis
Condition: Gastroparesis
Interventions: Drug: prucalopride;   Drug: placebo
29 Available Domperidone Expanded Access Program for Oncology Patients With Gastroparesis Who Have Failed Standard Therapy
Condition: Oncology Patients With Gastroparesis
Intervention: Drug: Oral Domperidone
30 Recruiting Different Acupoints Compatibility Difference of the Effect of Treatment of the Diabetic Gastroparesis
Condition: Diabetic Gastroparesis
Intervention: Device: acupuncture
31 Recruiting Pyloric Sphincter Pressure and Geometry Assessment Using EndoFlip
Condition: Gastroparesis
Intervention: Device: EndoFLIP
32 Recruiting Reference Values for Gastric Emptying
Condition: Delayed Gastric Emptying
Intervention: Other: Solid test meal, liquid test meal on two separate occations
33 Recruiting GI Neuromuscular Pathology Prospective Registry
Condition: Gastroparesis
Intervention:
34 Recruiting Escalating Temporary Gastric Electrical Stimulation (GES) for Severe Gastroparesis
Condition: Gastroparesis
Intervention:
35 Recruiting Study of Promethazine for Treatment of Diabetic Gastroparesis
Condition: Diabetic Gastroparesis
Interventions: Drug: Promethazine;   Drug: Sugar pill
36 Recruiting Gastroparesis Registry 2
Conditions: Gastroparesis;   Diabetic Gastroparesis;   Idiopathic Gastroparesis
Intervention:
37 Recruiting Evaluation of Diagnostic Methods and Dietary Treatment of Diabetic Gastroparesis
Condition: Diabetic Gastroparesis
Interventions: Dietary Supplement: dietary treatment: food of small particle size;   Radiation: Validate X-ray diagnostic method.;   Other: Can the motility be improved;   Biological: postprandial plasma glucose
38 Recruiting Gastric Pacemaker Implantation for Gastroparesis
Condition: Gastroparesis
Intervention: Device: Enterra Gastric Pacemaker
39 Not yet recruiting Protease Activated Receptor-2 and Gastrointestinal Dysfunction in Critical Illness
Conditions: Gastroparesis;   Gastrointestinal Disorder, Functional;   Critical Illness
Intervention:
40 Not yet recruiting Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Gastric Ulcer Participants With or Without Helicobacter Pylori Infection
Conditions: Gastric Ulcer;   Peptic Ulcer;   Gastrointestinal Diseases;   Digestive System Diseases;   Lansoprazole;   Anti-Ulcer Agents;   Gastrointestinal Agents;   Proton Pump Inhibitors;   Enzyme Inhibitors;   Molecular Mechanisms of Pharmacological Action
Interventions: Drug: TAK-438;   Drug: Lansoprazole;   Drug: TAK-438 Placebo;   Drug: Lansoprazole Placebo;   Drug: Bismuth-Containing Quadruple Therapy

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.